ORIC Pharmaceuticals, Inc.
ORIC
$4.99
-$0.32-6.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 203.72M | 255.96M | 272.37M | 286.41M | 316.78M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.71M | 6.29M | 7.06M | 8.19M | 7.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 211.43M | 262.25M | 279.43M | 294.60M | 324.08M |
|
|
|||||
| Total Current Assets | 211.43M | 262.25M | 279.43M | 294.60M | 324.08M |
| Net Property, Plant & Equipment | 3.02M | 11.30M | 3.09M | 2.88M | 2.80M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.37M | 588.00K | 9.55M | 9.30M | 9.21M |
| Total Assets | 242.86M | 274.14M | 302.07M | 328.91M | 350.79M |
|
|
|||||
| Total Accounts Payable | 5.16M | 1.55M | 4.25M | 2.31M | 2.99M |
| Total Accrued Expenses | 9.24M | 20.12M | 13.88M | 14.46M | 9.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.21M | 3.18M | 3.12M | 2.77M | 2.78M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 17.62M | 24.85M | 21.25M | 19.54M | 15.21M |
|
|
|||||
| Total Current Liabilities | 17.62M | 24.85M | 21.25M | 19.54M | 15.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.50M | 6.17M | 6.83M | 6.97M | 6.93M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.12M | 31.02M | 28.08M | 26.51M | 22.14M |
|
|
|||||
| Common Stock & APIC | 812.32M | 805.52M | 799.74M | 794.56M | 788.75M |
| Retained Earnings | -592.80M | -562.77M | -526.47M | -491.90M | -459.94M |
| Treasury Stock & Other | 209.00K | 379.00K | 722.00K | -256.00K | -162.00K |
| Total Common Equity | 219.74M | 243.12M | 273.99M | 302.40M | 328.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 219.74M | 243.12M | 273.99M | 302.40M | 328.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 219.74M | 243.12M | 273.99M | 302.40M | 328.65M |
|
|
|||||